These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 7303692

  • 1. [Treatment of pharmacotoxic psychoses with clopenthixol in patients with Parkinson's disease (author's transl)].
    Danielczyk W.
    Wien Klin Wochenschr; 1981 Aug 07; 93(15):500-1. PubMed ID: 7303692
    [Abstract] [Full Text] [Related]

  • 2. [Acute pharmacotoxic psychoses in patients with chronic cerebral disorders].
    Danielczyk W.
    Wien Med Wochenschr Suppl; 1979 Aug 07; 55():1-15. PubMed ID: 34935
    [Abstract] [Full Text] [Related]

  • 3. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P, Cote L, Fahn S.
    Adv Neurol; 1993 Aug 07; 60():703-6. PubMed ID: 8420214
    [No Abstract] [Full Text] [Related]

  • 4. [Pharmacotoxic psychoses in patients with neurological disorders during old age (author's transl)].
    Danielczyk W.
    Aktuelle Gerontol; 1979 Sep 07; 9(9):427-31. PubMed ID: 44122
    [Abstract] [Full Text] [Related]

  • 5. Clozapine treatment of psychosis in patients with Parkinson's disease.
    Friedman JH.
    J Clin Psychiatry; 1994 Feb 07; 55(2):79. PubMed ID: 8077160
    [No Abstract] [Full Text] [Related]

  • 6. [Psychological changes in Parkinson disease].
    Danielczyk W.
    Wien Med Wochenschr; 1986 Aug 31; 136(15-16):396-9. PubMed ID: 3788191
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Management of Parkinson's disease a review of current and new therapies.
    Mendis T, Suchowersky O, Lang A, Gauthier S.
    Can J Neurol Sci; 1999 May 31; 26(2):89-103. PubMed ID: 10352867
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
    Reddy S, Factor SA, Molho ES, Feustel PJ.
    Mov Disord; 2002 Jul 31; 17(4):676-81. PubMed ID: 12210856
    [Abstract] [Full Text] [Related]

  • 16. Dopaminergic psychosis in advanced Parkinson's disease.
    Fischer P, Danielczyk W, Simanyi M, Streifler MB.
    Adv Neurol; 1990 Jul 31; 53():391-7. PubMed ID: 2122647
    [No Abstract] [Full Text] [Related]

  • 17. Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.
    Rich SS, Friedman JH, Ott BR.
    J Clin Psychiatry; 1995 Dec 31; 56(12):556-9. PubMed ID: 8530331
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
    Melamed E, Zoldan J, Friedberg G, Ziv I, Weizmann A.
    Adv Neurol; 1996 Dec 31; 69():545-50. PubMed ID: 8615179
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.